TheraQuest Biosciences LLC
This article was originally published in Start Up
Executive Summary
Nearly all attempts to advance mechanistically novel pain medications beyond Phase II have failed over the past two decades due to efficacy or safety issues. Believing the risks associated with finding new drugs had grown too great, Najib Babul, PharmD, founded TheraQuest Biosciences LLC, using a jumpstart business model, to identify existing pain drugs that could be improved through reformulation.